描述头癌的微环境:对免疫疗法和预后的影响
Shabnam Varmazyari1, Hossein Borhani2, Zohreh Moradipour3
1Laser Research Center of Dentistry, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Advances in experimental medicine and biology
|November 12, 2025
概括
头癌 (HNCs) 面临着来自瘤微环境 (TME) 的挑战,该微环境促进免疫抑制. 调节TME为改善HNC治疗结果和患者存活率提供了新的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 头癌 (HNCs),主要是状细胞癌,尽管接受了治疗,但其复发率很高,存活率很差.
- 在HNC中的瘤微环境 (TME) 创造了一个免疫抑制的环境,促进瘤生长,入侵和对治疗的抗性.
研究的目的:
- 探索TME在HNC中的复杂作用及其对治疗结果,特别是免疫疗法的影响.
- 审查HNC TME的细胞和非细胞组件及其治疗影响.
- 讨论新的TME向疗法和预测/预后因素,以改善HNC治疗.
主要方法:
- 对HNC瘤微环境的当前文献的综述.
- 细胞组件 (纤维细胞,免疫细胞) 和非细胞基质的分析.
- 探索治疗策略 (免疫疗法,细胞移植,疫苗) 和生物标志物.
主要成果:
- TME包括多种细胞 (纤维细胞,免疫细胞) 和矩阵组件,促进HNC的免疫抑制.
- 特定的TME组件为向治疗带来了挑战和机遇.
- 免疫,遗传和微生物特征可以作为HNC的预测和预后因素.
结论:
- 调节HNC瘤微环境对于提高治疗疗效至关重要.
- 针对TME具有显著的希望,可以改善头癌患者的治疗结果.
- 了解TME复杂性是开发更有效的HNC疗法的关键.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.1K
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.9K
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
939
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
939
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
